People with severe mental illness more than four times as likely to die from pneumonia compared to the general population

Senior Patient Getting Vaccinated Sitting In Medical Center

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has found that people with severe mental illness (SMI) - such as bipolar disorder and schizophrenia - are more than four times as likely to die from pneumonia compared to the general population.

The research, published in eClinicalMedicine, suggests that people with SMI should be prioritised for preventative strategies including flu and pneumococcal vaccines.  

Researchers in this study conducted a systematic review of 29 studies to establish risk of mortality. In a sample of over two million people, a meta-analysis found that, compared to the general population, people with SMI were more than twice as likely to die from infectious diseases (including HIV, gastrointestinal diseases and hepatitis), and more than three times as likely to die from non-COVID respiratory infections. The risk of dying from pneumonia specifically was more than four times higher. 

There has been extensive research conducted that established that COVID-19 posed a significantly greater risk of death to people with SMI and this led to prioritisation of this group for COVID-19 vaccines. Comparatively little research has focused on other specific types of infectious diseases and this new study has shown that other respiratory infections such as pneumonia and flu could increase the risk of death in people with SMI.  

Professor Ioannis Bakolis, Professor of Public Mental Health and Statistics at King’s IoPPN and the study’s senior author said,

“While society has made great strides in the last two decades and has become much more accepting of mental illness, we have some way to go to recognising the wider health risks that those living with a severe mental illness face.

“Our study highlights the significantly increased risk of mortality associated with infectious disease that people with SMI still face. What’s important now is that, having identified the risk, public health policy recognises and adapts to provide better protections for those in need.”

The researchers go on to highlight several potential reasons as to why people with SMI face an increased risk. 

Dr Amy Ronaldson, an MQ Research Fellow at King’s IoPPN, and the study’s first author said,

“The nature of SMI means that it’s difficult to pinpoint a single reason as to why this group is at increased risk. What’s most likely is that it is a number of combined factors. 

“People with SMI already experience significant health inequalities, like reduced access to healthcare and stigma within the care system, that can dissuade people from approaching their doctor for help in the first place. This, combined with physical health factors, and the potential changes in the immune system that have been shown to be a feature of mental illness, creates a potent situation in which the effects of infectious disease can be much greater for someone managing SMI.” 

This study was possible thanks to support by the MQ Mental Health Research Fellowship, and with funding from the National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre (BRC).

 

Severe mental illness and infectious disease mortality: A systematic review and meta-analysis (Amy Ronaldson, Isabelle Nascimento Santana, Sophie Carlisle, Katie H Atmore, Natasha Chilman, Margaret Heslin, Sarah Markham, Alex Dregan, Jayati Das-Munshi, Temi Lampejo, Matthew Hotopf, Ioannis Bakolis) was published in eClinicalMedicine.

 


Tags: Informatics - CRIS -

By NIHR Maudsley BRC at 9 Oct 2024, 13:51 PM


Back to Blog List